Evrysdi from Roche for treatment of Spinal Muscular Atrophy now available in India
Jul 30, 2021, at 07:31 pm
Kolkata/IBNS: Evrysdi (risdiplam), launched by Roche, is the first and only approved treatment in India for Spinal Muscular Atrophy (SMA) patients, according to the company.